<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="description" content="Interactive data dashboard: Beta Blockers - comprehensive guide to types, benefits, side effects, and recommendations">
  <title>Beta Blockers | Data Dashboard</title>

  <style>
    :root {
      --color-primary: #3B82F6;
      --color-success: #10B981;
      --color-warning: #F59E0B;
      --color-danger: #EF4444;
      --color-purple: #8B5CF6;
      --color-pink: #EC4899;
      --color-text: #1F2937;
      --color-text-light: #6B7280;
      --color-bg: #FFFFFF;
      --color-bg-alt: #F3F4F6;
      --color-bg-card: #FFFFFF;
      --color-border: #E5E7EB;
      --font-sans: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
      --font-mono: 'SF Mono', Monaco, Consolas, monospace;
      --shadow-sm: 0 1px 2px rgba(0,0,0,0.05);
      --shadow-md: 0 4px 6px rgba(0,0,0,0.1);
      --shadow-lg: 0 10px 15px rgba(0,0,0,0.1);
      --radius: 12px;
      --radius-sm: 8px;
    }

    [data-theme="dark"] {
      --color-text: #F9FAFB;
      --color-text-light: #9CA3AF;
      --color-bg: #111827;
      --color-bg-alt: #1F2937;
      --color-bg-card: #1F2937;
      --color-border: #374151;
    }

    * { box-sizing: border-box; margin: 0; padding: 0; }

    body {
      font-family: var(--font-sans);
      background: var(--color-bg-alt);
      color: var(--color-text);
      line-height: 1.6;
    }

    /* Header */
    .dashboard-header {
      background: linear-gradient(135deg, #3B82F6 0%, #8B5CF6 100%);
      color: white;
      padding: 2rem;
      position: sticky;
      top: 0;
      z-index: 100;
    }

    .header-content {
      max-width: 1400px;
      margin: 0 auto;
      display: flex;
      justify-content: space-between;
      align-items: center;
      flex-wrap: wrap;
      gap: 1rem;
    }

    .dashboard-title {
      font-size: 1.75rem;
      font-weight: 700;
    }

    .dashboard-subtitle {
      font-size: 0.95rem;
      opacity: 0.9;
      margin-top: 0.25rem;
    }

    .dashboard-meta {
      font-size: 0.875rem;
      opacity: 0.85;
    }

    /* Navigation */
    .category-nav {
      background: var(--color-bg);
      border-bottom: 1px solid var(--color-border);
      padding: 0 2rem;
      overflow-x: auto;
      position: sticky;
      top: 0;
      z-index: 99;
    }

    .nav-list {
      max-width: 1400px;
      margin: 0 auto;
      display: flex;
      gap: 0.25rem;
      list-style: none;
    }

    .nav-item {
      padding: 1rem 1.25rem;
      color: var(--color-text-light);
      text-decoration: none;
      border-bottom: 3px solid transparent;
      white-space: nowrap;
      transition: all 0.2s;
      font-size: 0.9rem;
      font-weight: 500;
    }

    .nav-item:hover,
    .nav-item.active {
      color: var(--color-primary);
      border-bottom-color: var(--color-primary);
    }

    /* Main Container */
    .dashboard-container {
      max-width: 1400px;
      margin: 0 auto;
      padding: 2rem;
    }

    /* Hero Stats */
    .hero-stats {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
      gap: 1.5rem;
      margin-bottom: 3rem;
    }

    .stat-card {
      background: var(--color-bg-card);
      border-radius: var(--radius);
      padding: 1.5rem;
      box-shadow: var(--shadow-sm);
      border: 1px solid var(--color-border);
      transition: transform 0.2s, box-shadow 0.2s;
    }

    .stat-card:hover {
      transform: translateY(-2px);
      box-shadow: var(--shadow-md);
    }

    .stat-card.highlight {
      border-left: 4px solid var(--color-primary);
    }

    .stat-card.success {
      border-left: 4px solid var(--color-success);
    }

    .stat-card.warning {
      border-left: 4px solid var(--color-warning);
    }

    .stat-card.danger {
      border-left: 4px solid var(--color-danger);
    }

    .stat-label {
      font-size: 0.875rem;
      color: var(--color-text-light);
      margin-bottom: 0.5rem;
      text-transform: uppercase;
      letter-spacing: 0.05em;
    }

    .stat-value {
      font-size: 2.25rem;
      font-weight: 700;
      color: var(--color-text);
      line-height: 1.2;
    }

    .stat-context {
      font-size: 0.875rem;
      color: var(--color-text-light);
      margin-top: 0.5rem;
    }

    .stat-source {
      font-size: 0.75rem;
      color: var(--color-text-light);
      margin-top: 0.75rem;
      padding-top: 0.75rem;
      border-top: 1px solid var(--color-border);
    }

    .stat-source a {
      color: var(--color-primary);
      text-decoration: none;
    }

    .stat-source a:hover {
      text-decoration: underline;
    }

    /* Section */
    .data-section {
      margin-bottom: 3rem;
      scroll-margin-top: 140px;
    }

    .section-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 1.5rem;
      flex-wrap: wrap;
      gap: 1rem;
    }

    .section-title {
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--color-text);
    }

    .section-subtitle {
      font-size: 0.95rem;
      color: var(--color-text-light);
      margin-top: 0.25rem;
    }

    /* Drug Cards */
    .drug-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(350px, 1fr));
      gap: 1.5rem;
    }

    .drug-card {
      background: var(--color-bg-card);
      border-radius: var(--radius);
      overflow: hidden;
      box-shadow: var(--shadow-sm);
      border: 1px solid var(--color-border);
    }

    .drug-header {
      padding: 1.25rem 1.5rem;
      background: linear-gradient(135deg, var(--color-primary) 0%, var(--color-purple) 100%);
      color: white;
    }

    .drug-header.gen1 {
      background: linear-gradient(135deg, #6B7280 0%, #4B5563 100%);
    }

    .drug-header.gen2 {
      background: linear-gradient(135deg, #3B82F6 0%, #2563EB 100%);
    }

    .drug-header.gen3 {
      background: linear-gradient(135deg, #10B981 0%, #059669 100%);
    }

    .drug-name {
      font-size: 1.25rem;
      font-weight: 700;
      margin-bottom: 0.25rem;
    }

    .drug-brand {
      font-size: 0.875rem;
      opacity: 0.9;
    }

    .drug-class {
      display: inline-block;
      margin-top: 0.5rem;
      padding: 0.25rem 0.75rem;
      background: rgba(255,255,255,0.2);
      border-radius: 20px;
      font-size: 0.75rem;
      font-weight: 500;
    }

    .drug-body {
      padding: 1.5rem;
    }

    .drug-description {
      font-size: 0.9rem;
      color: var(--color-text-light);
      margin-bottom: 1rem;
      line-height: 1.5;
    }

    .drug-section-title {
      font-size: 0.8rem;
      font-weight: 600;
      color: var(--color-text);
      margin: 1rem 0 0.5rem;
      text-transform: uppercase;
      letter-spacing: 0.05em;
    }

    .drug-list {
      list-style: none;
      font-size: 0.875rem;
    }

    .drug-list li {
      padding: 0.35rem 0;
      padding-left: 1.25rem;
      position: relative;
      color: var(--color-text-light);
    }

    .drug-list li::before {
      content: '';
      position: absolute;
      left: 0;
      top: 0.7rem;
      width: 6px;
      height: 6px;
      border-radius: 50%;
      background: var(--color-primary);
    }

    .drug-list.benefits li::before {
      background: var(--color-success);
    }

    .drug-list.drawbacks li::before {
      background: var(--color-danger);
    }

    .drug-list.side-effects li::before {
      background: var(--color-warning);
    }

    .drug-tags {
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem;
      margin-top: 1rem;
    }

    .drug-tag {
      padding: 0.25rem 0.75rem;
      background: var(--color-bg-alt);
      border-radius: 20px;
      font-size: 0.75rem;
      color: var(--color-text-light);
    }

    .drug-source {
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid var(--color-border);
      font-size: 0.75rem;
      color: var(--color-text-light);
    }

    .drug-source a {
      color: var(--color-primary);
      text-decoration: none;
    }

    /* Expandable sections */
    .expand-toggle {
      background: none;
      border: none;
      color: var(--color-primary);
      cursor: pointer;
      font-size: 0.875rem;
      padding: 0.5rem 0;
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .expand-content {
      display: none;
      padding-top: 0.5rem;
    }

    .expand-content.show {
      display: block;
    }

    /* Comparison Table */
    .comparison-table-wrapper {
      overflow-x: auto;
      background: var(--color-bg-card);
      border-radius: var(--radius);
      box-shadow: var(--shadow-sm);
      border: 1px solid var(--color-border);
    }

    .comparison-table {
      width: 100%;
      min-width: 800px;
      border-collapse: collapse;
    }

    .comparison-table th,
    .comparison-table td {
      padding: 1rem;
      text-align: left;
      border-bottom: 1px solid var(--color-border);
    }

    .comparison-table th {
      background: var(--color-bg-alt);
      font-weight: 600;
      font-size: 0.875rem;
      color: var(--color-text);
      position: sticky;
      top: 0;
    }

    .comparison-table td {
      font-size: 0.875rem;
      color: var(--color-text-light);
      vertical-align: top;
    }

    .comparison-table tr:last-child td {
      border-bottom: none;
    }

    .comparison-table tr:hover td {
      background: var(--color-bg-alt);
    }

    .comparison-table .drug-name-cell {
      font-weight: 600;
      color: var(--color-text);
    }

    /* Badges */
    .badge {
      display: inline-block;
      padding: 0.2rem 0.5rem;
      border-radius: 4px;
      font-size: 0.7rem;
      font-weight: 600;
      text-transform: uppercase;
    }

    .badge-gen1 {
      background: #E5E7EB;
      color: #4B5563;
    }

    .badge-gen2 {
      background: #DBEAFE;
      color: #1D4ED8;
    }

    .badge-gen3 {
      background: #D1FAE5;
      color: #047857;
    }

    .badge-selective {
      background: #FEF3C7;
      color: #92400E;
    }

    .badge-nonselective {
      background: #FEE2E2;
      color: #B91C1C;
    }

    /* Chart Container */
    .chart-card {
      background: var(--color-bg-card);
      border-radius: var(--radius);
      padding: 1.5rem;
      box-shadow: var(--shadow-sm);
      border: 1px solid var(--color-border);
    }

    .chart-title {
      font-size: 1rem;
      font-weight: 600;
      margin-bottom: 0.5rem;
    }

    .chart-subtitle {
      font-size: 0.85rem;
      color: var(--color-text-light);
      margin-bottom: 1rem;
    }

    .chart-container {
      position: relative;
      width: 100%;
      height: 350px;
    }

    /* Data Grid */
    .data-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
      gap: 1.5rem;
    }

    /* Withdrawal Section */
    .timeline {
      position: relative;
      padding-left: 2rem;
    }

    .timeline::before {
      content: '';
      position: absolute;
      left: 0;
      top: 0;
      bottom: 0;
      width: 2px;
      background: var(--color-border);
    }

    .timeline-item {
      position: relative;
      padding-bottom: 1.5rem;
    }

    .timeline-item::before {
      content: '';
      position: absolute;
      left: -2rem;
      top: 0.25rem;
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--color-primary);
      border: 2px solid var(--color-bg);
      transform: translateX(-5px);
    }

    .timeline-item.danger::before {
      background: var(--color-danger);
    }

    .timeline-item.warning::before {
      background: var(--color-warning);
    }

    .timeline-time {
      font-size: 0.875rem;
      font-weight: 600;
      color: var(--color-text);
      margin-bottom: 0.25rem;
    }

    .timeline-content {
      font-size: 0.875rem;
      color: var(--color-text-light);
    }

    /* Indication Cards */
    .indication-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
      gap: 1rem;
    }

    .indication-card {
      background: var(--color-bg-card);
      border-radius: var(--radius-sm);
      padding: 1.25rem;
      border: 1px solid var(--color-border);
    }

    .indication-title {
      font-size: 1rem;
      font-weight: 600;
      color: var(--color-text);
      margin-bottom: 0.75rem;
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .indication-title .icon {
      font-size: 1.25rem;
    }

    .indication-drugs {
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem;
    }

    .indication-drug {
      padding: 0.35rem 0.75rem;
      background: var(--color-bg-alt);
      border-radius: 20px;
      font-size: 0.8rem;
      font-weight: 500;
      color: var(--color-text);
    }

    .indication-drug.primary {
      background: var(--color-primary);
      color: white;
    }

    .indication-note {
      margin-top: 0.75rem;
      font-size: 0.8rem;
      color: var(--color-text-light);
      font-style: italic;
    }

    .indication-source {
      margin-top: 0.5rem;
      font-size: 0.7rem;
    }

    .indication-source a {
      color: var(--color-primary);
      text-decoration: none;
    }

    /* Side Effects Grid */
    .side-effects-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
      gap: 1rem;
    }

    .side-effect-category {
      background: var(--color-bg-card);
      border-radius: var(--radius-sm);
      padding: 1.25rem;
      border: 1px solid var(--color-border);
    }

    .side-effect-title {
      font-size: 0.9rem;
      font-weight: 600;
      color: var(--color-text);
      margin-bottom: 0.75rem;
      padding-bottom: 0.5rem;
      border-bottom: 2px solid var(--color-primary);
    }

    .side-effect-title.common {
      border-bottom-color: var(--color-success);
    }

    .side-effect-title.uncommon {
      border-bottom-color: var(--color-warning);
    }

    .side-effect-title.serious {
      border-bottom-color: var(--color-danger);
    }

    .side-effect-list {
      list-style: none;
      font-size: 0.85rem;
    }

    .side-effect-list li {
      padding: 0.3rem 0;
      color: var(--color-text-light);
    }

    /* Contraindications */
    .contra-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(350px, 1fr));
      gap: 1.5rem;
    }

    .contra-card {
      background: var(--color-bg-card);
      border-radius: var(--radius);
      overflow: hidden;
      border: 1px solid var(--color-border);
    }

    .contra-header {
      padding: 1rem 1.5rem;
      font-weight: 600;
    }

    .contra-header.absolute {
      background: #FEE2E2;
      color: #B91C1C;
    }

    .contra-header.relative {
      background: #FEF3C7;
      color: #92400E;
    }

    .contra-body {
      padding: 1.5rem;
    }

    .contra-list {
      list-style: none;
    }

    .contra-list li {
      padding: 0.75rem 0;
      border-bottom: 1px solid var(--color-border);
      font-size: 0.9rem;
    }

    .contra-list li:last-child {
      border-bottom: none;
    }

    .contra-condition {
      font-weight: 500;
      color: var(--color-text);
    }

    .contra-reason {
      font-size: 0.8rem;
      color: var(--color-text-light);
      margin-top: 0.25rem;
    }

    /* Drug Interactions */
    .interactions-table {
      width: 100%;
      background: var(--color-bg-card);
      border-radius: var(--radius);
      overflow: hidden;
      border: 1px solid var(--color-border);
    }

    .interactions-table th,
    .interactions-table td {
      padding: 1rem;
      text-align: left;
      border-bottom: 1px solid var(--color-border);
    }

    .interactions-table th {
      background: var(--color-bg-alt);
      font-weight: 600;
      font-size: 0.875rem;
    }

    .severity-high {
      color: var(--color-danger);
      font-weight: 600;
    }

    .severity-moderate {
      color: var(--color-warning);
      font-weight: 600;
    }

    /* Footnotes */
    .footnotes {
      background: var(--color-bg-card);
      border-radius: var(--radius);
      padding: 1.5rem;
      border: 1px solid var(--color-border);
      margin-top: 2rem;
    }

    .footnotes-title {
      font-size: 1.25rem;
      font-weight: 600;
      margin-bottom: 1rem;
    }

    .footnote-item {
      padding: 0.5rem 0;
      font-size: 0.85rem;
      border-bottom: 1px solid var(--color-border);
      display: flex;
      gap: 0.75rem;
    }

    .footnote-item:last-child {
      border-bottom: none;
    }

    .footnote-number {
      font-weight: 600;
      color: var(--color-primary);
      min-width: 24px;
    }

    .footnote-text a {
      color: var(--color-primary);
      text-decoration: none;
      word-break: break-all;
    }

    .footnote-text a:hover {
      text-decoration: underline;
    }

    sup a {
      color: var(--color-primary);
      text-decoration: none;
      font-weight: 600;
    }

    /* Footer */
    .dashboard-footer {
      background: var(--color-bg);
      border-top: 1px solid var(--color-border);
      padding: 2rem;
      margin-top: 3rem;
    }

    .footer-content {
      max-width: 1400px;
      margin: 0 auto;
    }

    .footer-disclaimer {
      background: #FEF3C7;
      border: 1px solid #F59E0B;
      border-radius: var(--radius-sm);
      padding: 1rem 1.5rem;
      margin-bottom: 1.5rem;
      font-size: 0.875rem;
      color: #92400E;
    }

    /* Theme Toggle */
    .theme-toggle {
      position: fixed;
      bottom: 1.5rem;
      right: 1.5rem;
      background: var(--color-bg-card);
      border: 1px solid var(--color-border);
      border-radius: 50px;
      padding: 0.75rem 1.25rem;
      cursor: pointer;
      box-shadow: var(--shadow-lg);
      font-size: 0.875rem;
      display: flex;
      align-items: center;
      gap: 0.5rem;
      z-index: 1000;
      color: var(--color-text);
    }

    .theme-toggle:hover {
      background: var(--color-bg-alt);
    }

    /* Responsive */
    @media (max-width: 768px) {
      .hero-stats {
        grid-template-columns: 1fr;
      }
      .stat-value {
        font-size: 1.75rem;
      }
      .dashboard-container {
        padding: 1rem;
      }
      .drug-grid {
        grid-template-columns: 1fr;
      }
      .data-grid {
        grid-template-columns: 1fr;
      }
      .section-title {
        font-size: 1.25rem;
      }
      .dashboard-title {
        font-size: 1.35rem;
      }
      .nav-item {
        padding: 0.75rem 1rem;
        font-size: 0.8rem;
      }
    }

    @media print {
      .category-nav, .theme-toggle { display: none; }
      .dashboard-header { position: static; }
      .data-section { page-break-inside: avoid; }
    }

    /* Scroll to top */
    .scroll-top {
      position: fixed;
      bottom: 1.5rem;
      left: 1.5rem;
      background: var(--color-primary);
      color: white;
      border: none;
      border-radius: 50%;
      width: 48px;
      height: 48px;
      cursor: pointer;
      box-shadow: var(--shadow-lg);
      font-size: 1.25rem;
      display: none;
      align-items: center;
      justify-content: center;
      z-index: 1000;
    }

    .scroll-top.show {
      display: flex;
    }
  </style>
</head>
<body>
  <header class="dashboard-header">
    <div class="header-content">
      <div>
        <h1 class="dashboard-title">Beta Blockers Data Dashboard</h1>
        <p class="dashboard-subtitle">Comprehensive guide to beta-adrenergic blocking agents</p>
      </div>
      <div class="dashboard-meta">
        <div>Last updated: December 18, 2025</div>
        <div>45 sources cited</div>
      </div>
    </div>
  </header>

  <nav class="category-nav">
    <ul class="nav-list">
      <li><a href="#overview" class="nav-item active">Overview</a></li>
      <li><a href="#drugs" class="nav-item">Drug Profiles</a></li>
      <li><a href="#comparison" class="nav-item">Comparison</a></li>
      <li><a href="#side-effects" class="nav-item">Side Effects</a></li>
      <li><a href="#withdrawal" class="nav-item">Withdrawal</a></li>
      <li><a href="#recommendations" class="nav-item">Recommendations</a></li>
      <li><a href="#contraindications" class="nav-item">Contraindications</a></li>
      <li><a href="#interactions" class="nav-item">Interactions</a></li>
      <li><a href="#sources" class="nav-item">Sources</a></li>
    </ul>
  </nav>

  <main class="dashboard-container">
    <!-- Hero Stats -->
    <section class="hero-stats" id="overview">
      <div class="stat-card highlight">
        <div class="stat-label">Most Prescribed (US 2024)</div>
        <div class="stat-value">Metoprolol</div>
        <div class="stat-context">36.9% market share (succinate) + 16.7% (tartrate)</div>
        <div class="stat-source">Source: <a href="https://www.definitivehc.com/blog/beta-blocker-prescription-patterns" target="_blank">Definitive Healthcare</a><sup><a href="#fn1">[1]</a></sup></div>
      </div>

      <div class="stat-card success">
        <div class="stat-label">Generations</div>
        <div class="stat-value">3</div>
        <div class="stat-context">Non-selective, Cardioselective, Vasodilating</div>
        <div class="stat-source">Source: <a href="https://pubmed.ncbi.nlm.nih.gov/30227820/" target="_blank">PubMed</a><sup><a href="#fn2">[2]</a></sup></div>
      </div>

      <div class="stat-card warning">
        <div class="stat-label">Withdrawal Peak</div>
        <div class="stat-value">48-72 hrs</div>
        <div class="stat-context">Maximum heart rate increase after abrupt cessation</div>
        <div class="stat-source">Source: <a href="https://pubmed.ncbi.nlm.nih.gov/37093/" target="_blank">Eur J Clin Pharmacol</a><sup><a href="#fn3">[3]</a></sup></div>
      </div>

      <div class="stat-card danger">
        <div class="stat-label">Sotalol QT Risk</div>
        <div class="stat-value">1-5%</div>
        <div class="stat-context">Torsades de pointes risk (dose-dependent)</div>
        <div class="stat-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK534832/" target="_blank">StatPearls</a><sup><a href="#fn4">[4]</a></sup></div>
      </div>
    </section>

    <!-- What Are Beta Blockers -->
    <section class="data-section" id="intro">
      <div class="section-header">
        <div>
          <h2 class="section-title">What Are Beta Blockers?</h2>
          <p class="section-subtitle">Essential information about beta-adrenergic blocking agents</p>
        </div>
      </div>

      <div class="chart-card">
        <p style="font-size: 0.95rem; line-height: 1.7; color: var(--color-text-light); margin-bottom: 1rem;">
          Beta-blockers (beta-adrenergic blocking agents) are medications that block the effects of adrenaline (epinephrine) and other stress hormones on beta-adrenergic receptors. First developed by Scottish scientist <strong>James W. Black</strong> in the 1960s, they revolutionized the treatment of cardiovascular disease.<sup><a href="#fn5">[5]</a></sup>
        </p>
        <p style="font-size: 0.95rem; line-height: 1.7; color: var(--color-text-light); margin-bottom: 1rem;">
          By blocking beta receptors, these drugs reduce heart rate, decrease blood pressure, lower cardiac oxygen demand, and help stabilize heart rhythm. They are FDA-approved for treating <strong>hypertension, heart failure, arrhythmias, angina, post-myocardial infarction, migraine prophylaxis, essential tremor, hyperthyroidism, glaucoma</strong>, and other conditions.<sup><a href="#fn6">[6]</a></sup>
        </p>
        <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(200px, 1fr)); gap: 1rem; margin-top: 1.5rem;">
          <div style="text-align: center; padding: 1rem; background: var(--color-bg-alt); border-radius: var(--radius-sm);">
            <div style="font-size: 1.5rem; font-weight: 700; color: var(--color-primary);">1960s</div>
            <div style="font-size: 0.8rem; color: var(--color-text-light);">First beta blocker developed</div>
          </div>
          <div style="text-align: center; padding: 1rem; background: var(--color-bg-alt); border-radius: var(--radius-sm);">
            <div style="font-size: 1.5rem; font-weight: 700; color: var(--color-success);">12+</div>
            <div style="font-size: 0.8rem; color: var(--color-text-light);">Individual agents available</div>
          </div>
          <div style="text-align: center; padding: 1rem; background: var(--color-bg-alt); border-radius: var(--radius-sm);">
            <div style="font-size: 1.5rem; font-weight: 700; color: var(--color-purple);">10+</div>
            <div style="font-size: 0.8rem; color: var(--color-text-light);">FDA-approved indications</div>
          </div>
        </div>
      </div>
    </section>

    <!-- Generations Overview -->
    <section class="data-section" id="generations">
      <div class="section-header">
        <h2 class="section-title">Three Generations of Beta Blockers</h2>
      </div>

      <div class="data-grid">
        <div class="chart-card">
          <h3 class="chart-title">First Generation (Non-Selective)</h3>
          <p class="chart-subtitle">Block both beta-1 and beta-2 receptors</p>
          <ul class="drug-list" style="margin-top: 1rem;">
            <li><strong>Examples:</strong> Propranolol, Nadolol, Timolol, Pindolol, Sotalol</li>
            <li>Affect heart, lungs, vessels, GI tract, and metabolism</li>
            <li>Higher risk of bronchospasm - avoid in asthma</li>
            <li>More CNS and metabolic side effects</li>
          </ul>
          <div class="stat-source">Source: <a href="https://pubmed.ncbi.nlm.nih.gov/30227820/" target="_blank">PubMed</a><sup><a href="#fn2">[2]</a></sup></div>
        </div>

        <div class="chart-card">
          <h3 class="chart-title">Second Generation (Cardioselective)</h3>
          <p class="chart-subtitle">Preferentially block beta-1 receptors</p>
          <ul class="drug-list" style="margin-top: 1rem;">
            <li><strong>Examples:</strong> Metoprolol, Atenolol, Bisoprolol, Acebutolol, Esmolol</li>
            <li>Primary effect on heart - less lung/peripheral effects</li>
            <li>Safer in mild asthma/COPD (with caution)</li>
            <li>Better tolerability than first generation</li>
          </ul>
          <div class="stat-source">Source: <a href="https://pubmed.ncbi.nlm.nih.gov/30227820/" target="_blank">PubMed</a><sup><a href="#fn2">[2]</a></sup></div>
        </div>

        <div class="chart-card">
          <h3 class="chart-title">Third Generation (Vasodilating)</h3>
          <p class="chart-subtitle">Beta blockade + vasodilation via alpha-blockade or NO release</p>
          <ul class="drug-list" style="margin-top: 1rem;">
            <li><strong>Examples:</strong> Carvedilol, Labetalol, Nebivolol</li>
            <li>Additional vasodilatory properties</li>
            <li>No unfavorable metabolic effects</li>
            <li>Better for diabetics - metabolically neutral</li>
          </ul>
          <div class="stat-source">Source: <a href="https://onlinelibrary.wiley.com/doi/10.1111/bcpt.12396" target="_blank">Wiley</a><sup><a href="#fn7">[7]</a></sup></div>
        </div>
      </div>
    </section>

    <!-- Market Share Chart -->
    <section class="data-section">
      <div class="section-header">
        <h2 class="section-title">US Prescription Market Share (2024)</h2>
      </div>

      <div class="chart-card">
        <div class="chart-container">
          <canvas id="marketShareChart"></canvas>
        </div>
        <div class="stat-source" style="margin-top: 1rem;">Source: <a href="https://www.definitivehc.com/blog/beta-blocker-prescription-patterns" target="_blank">Definitive Healthcare</a><sup><a href="#fn1">[1]</a></sup></div>
      </div>
    </section>

    <!-- Drug Profiles -->
    <section class="data-section" id="drugs">
      <div class="section-header">
        <div>
          <h2 class="section-title">Individual Beta Blocker Profiles</h2>
          <p class="section-subtitle">Detailed information on each major beta blocker</p>
        </div>
      </div>

      <div class="drug-grid">
        <!-- Metoprolol -->
        <div class="drug-card">
          <div class="drug-header gen2">
            <div class="drug-name">Metoprolol</div>
            <div class="drug-brand">Lopressor, Toprol-XL</div>
            <span class="drug-class">2nd Generation - Beta-1 Selective</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              The most prescribed beta blocker in the US. Available as immediate-release (tartrate) and extended-release (succinate). Proven mortality reduction in heart failure and post-MI.<sup><a href="#fn6">[6]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Hypertension</span>
              <span class="drug-tag">Heart Failure (HFrEF)</span>
              <span class="drug-tag">Post-MI</span>
              <span class="drug-tag">Angina</span>
              <span class="drug-tag">Arrhythmias</span>
              <span class="drug-tag">Migraine Prophylaxis</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Most prescribed - extensive clinical data<sup><a href="#fn1">[1]</a></sup></li>
              <li>Proven mortality reduction in heart failure<sup><a href="#fn8">[8]</a></sup></li>
              <li>Safer than non-selective agents in asthma/COPD</li>
              <li>Once-daily dosing with succinate form</li>
              <li>Inexpensive and widely available</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>Tartrate requires twice-daily dosing</li>
              <li>Can cause fatigue, dizziness, cold extremities</li>
              <li>Must be tapered - do not stop abruptly<sup><a href="#fn9">[9]</a></sup></li>
              <li>May cause weight gain</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Bradycardia, fatigue, dizziness</li>
              <li>Cold extremities, weight gain</li>
              <li>Depression, vivid dreams</li>
              <li>Erectile dysfunction</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://www.ncbi.nlm.nih.gov/books/NBK532906/" target="_blank">StatPearls</a><sup><a href="#fn6">[6]</a></sup>,
              <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9823244/" target="_blank">PMC</a><sup><a href="#fn8">[8]</a></sup>
            </div>
          </div>
        </div>

        <!-- Carvedilol -->
        <div class="drug-card">
          <div class="drug-header gen3">
            <div class="drug-name">Carvedilol</div>
            <div class="drug-brand">Coreg</div>
            <span class="drug-class">3rd Generation - Non-selective + Alpha Blocker</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Third-generation beta blocker with dual mechanism: blocks beta-1, beta-2, AND alpha-1 receptors. Provides vasodilation and has antioxidant properties. Preferred for diabetics due to metabolically neutral profile.<sup><a href="#fn8">[8]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Heart Failure (HFrEF)</span>
              <span class="drug-tag">Post-MI</span>
              <span class="drug-tag">Hypertension</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Dual mechanism provides vasodilation<sup><a href="#fn8">[8]</a></sup></li>
              <li>Better metabolic profile - improves insulin sensitivity<sup><a href="#fn10">[10]</a></sup></li>
              <li>Lower risk of new-onset type 2 diabetes</li>
              <li>Antioxidant and antiproliferative effects</li>
              <li>COMET trial: superior to metoprolol for HF mortality<sup><a href="#fn8">[8]</a></sup></li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>Requires twice-daily dosing</li>
              <li>Non-selective - caution in asthma</li>
              <li>More hypotension due to alpha-blockade</li>
              <li>Drug interactions (especially with digoxin)</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Dizziness, fatigue, hypotension</li>
              <li>Diarrhea, weight gain</li>
              <li>Bradycardia, hyperglycemia</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9823244/" target="_blank">PMC</a><sup><a href="#fn8">[8]</a></sup>,
              <a href="https://www.ahajournals.org/doi/10.1161/JAHA.121.021310" target="_blank">JAHA</a><sup><a href="#fn10">[10]</a></sup>
            </div>
          </div>
        </div>

        <!-- Propranolol -->
        <div class="drug-card">
          <div class="drug-header gen1">
            <div class="drug-name">Propranolol</div>
            <div class="drug-brand">Inderal</div>
            <span class="drug-class">1st Generation - Non-Selective</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              The first successful beta blocker, developed by James W. Black in the 1960s. Wide range of uses including performance anxiety, tremor, and hyperthyroidism. Crosses blood-brain barrier (helps with anxiety/tremor but causes CNS effects).<sup><a href="#fn5">[5]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Hypertension</span>
              <span class="drug-tag">Migraine</span>
              <span class="drug-tag">Essential Tremor</span>
              <span class="drug-tag">Performance Anxiety</span>
              <span class="drug-tag">Hyperthyroidism</span>
              <span class="drug-tag">Portal HTN</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>First and most studied beta blocker<sup><a href="#fn5">[5]</a></sup></li>
              <li>Wide range of approved indications</li>
              <li>Effective for performance anxiety and tremor<sup><a href="#fn5">[5]</a></sup></li>
              <li>Most studied for hyperthyroidism symptoms</li>
              <li>Used for infantile hemangioma</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>Non-selective - contraindicated in asthma</li>
              <li>CNS effects (crosses blood-brain barrier)</li>
              <li>Can mask hypoglycemia symptoms</li>
              <li>Multiple daily doses (short half-life: 3-6 hrs)<sup><a href="#fn5">[5]</a></sup></li>
              <li>Smoking decreases effectiveness</li>
              <li>Most severe withdrawal symptoms<sup><a href="#fn11">[11]</a></sup></li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Bradycardia, fatigue, cold extremities</li>
              <li>Bronchospasm, GI upset, vivid dreams</li>
              <li>Depression, short-term memory effects</li>
              <li>Erectile dysfunction</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://www.ncbi.nlm.nih.gov/books/NBK557801/" target="_blank">StatPearls</a><sup><a href="#fn5">[5]</a></sup>
            </div>
          </div>
        </div>

        <!-- Bisoprolol -->
        <div class="drug-card">
          <div class="drug-header gen2">
            <div class="drug-name">Bisoprolol</div>
            <div class="drug-brand">Zebeta</div>
            <span class="drug-class">2nd Generation - Highly Beta-1 Selective</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Highly cardioselective beta blocker with once-daily dosing. Shows superior survival benefit in COPD patients with heart failure compared to carvedilol or metoprolol.<sup><a href="#fn12">[12]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Heart Failure (HFrEF)</span>
              <span class="drug-tag">Hypertension</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Highest beta-1 selectivity among common agents</li>
              <li>Once-daily dosing</li>
              <li>Superior survival in HF + COPD patients<sup><a href="#fn12">[12]</a></sup></li>
              <li>Evidence-based for heart failure</li>
              <li>Similar efficacy to carvedilol with better tolerability</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>Less commonly prescribed in US</li>
              <li>Limited data for some indications</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Fatigue, headache, dizziness</li>
              <li>Cold extremities, GI upset</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://link.springer.com/article/10.1007/s00392-017-1115-0" target="_blank">Clin Res Cardiol</a><sup><a href="#fn12">[12]</a></sup>
            </div>
          </div>
        </div>

        <!-- Nebivolol -->
        <div class="drug-card">
          <div class="drug-header gen3">
            <div class="drug-name">Nebivolol</div>
            <div class="drug-brand">Bystolic</div>
            <span class="drug-class">3rd Generation - Beta-1 Selective + NO Release</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              The only beta blocker that stimulates nitric oxide production, providing unique vasodilatory properties. Improves endothelial function and has better tolerability profile (less fatigue, less sexual dysfunction).<sup><a href="#fn13">[13]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Hypertension</span>
              <span class="drug-tag">Heart Failure (Europe)</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Only BB that stimulates nitric oxide production<sup><a href="#fn13">[13]</a></sup></li>
              <li>Improves endothelial function</li>
              <li>Less fatigue, less sexual dysfunction</li>
              <li>Does not decrease nocturnal melatonin (better sleep)<sup><a href="#fn7">[7]</a></sup></li>
              <li>Beneficial for diabetics, elderly, African-Americans<sup><a href="#fn13">[13]</a></sup></li>
              <li>Does not inhibit exercise heart rate at doses &lt;10mg</li>
              <li>Antioxidant properties</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>More expensive than older agents</li>
              <li>Less outcome data than metoprolol/carvedilol for HF</li>
              <li>Limited availability in some regions</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Headache, fatigue, dizziness, diarrhea</li>
              <li>(Generally well-tolerated)</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1993984/" target="_blank">PMC</a><sup><a href="#fn13">[13]</a></sup>
            </div>
          </div>
        </div>

        <!-- Atenolol -->
        <div class="drug-card">
          <div class="drug-header gen2">
            <div class="drug-name">Atenolol</div>
            <div class="drug-brand">Tenormin</div>
            <span class="drug-class">2nd Generation - Beta-1 Selective</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Cardioselective, water-soluble beta blocker with once-daily dosing. Good for blood pressure control but notably does NOT have proven mortality reduction post-MI like metoprolol.<sup><a href="#fn14">[14]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Hypertension</span>
              <span class="drug-tag">Angina</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Once-daily dosing</li>
              <li>Cardioselective</li>
              <li>Good blood pressure control</li>
              <li>Water-soluble - fewer CNS effects</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>NO proven mortality reduction post-MI<sup><a href="#fn15">[15]</a></sup></li>
              <li>Requires dose adjustment in renal impairment</li>
              <li>Inferior to metoprolol for CV outcomes<sup><a href="#fn14">[14]</a></sup></li>
              <li>Not recommended first-line for elderly with HTN<sup><a href="#fn16">[16]</a></sup></li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Fatigue, dizziness, cold extremities</li>
              <li>Bradycardia, GI upset</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://www.singlecare.com/blog/metoprolol-vs-atenolol/" target="_blank">SingleCare</a><sup><a href="#fn14">[14]</a></sup>
            </div>
          </div>
        </div>

        <!-- Sotalol -->
        <div class="drug-card">
          <div class="drug-header gen1">
            <div class="drug-name">Sotalol</div>
            <div class="drug-brand">Betapace</div>
            <span class="drug-class">1st Gen Non-Selective + Class III Antiarrhythmic</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Unique beta blocker with additional Class III antiarrhythmic properties (potassium channel blockade). Used primarily for arrhythmias but carries significant QT prolongation risk - requires in-hospital initiation with ECG monitoring.<sup><a href="#fn4">[4]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Ventricular Tachycardia</span>
              <span class="drug-tag">Atrial Fibrillation</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Dual beta-blocker and antiarrhythmic effects<sup><a href="#fn4">[4]</a></sup></li>
              <li>Effective for ventricular and supraventricular arrhythmias</li>
              <li>Maintains sinus rhythm in AF</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>QT prolongation risk (dose-dependent)<sup><a href="#fn4">[4]</a></sup></li>
              <li>Torsades de pointes risk: 1% (&lt;320mg) to 5% (&gt;320mg)</li>
              <li>Requires in-hospital initiation with ECG monitoring</li>
              <li>Cannot use with other QT-prolonging drugs</li>
              <li>Contraindicated in long QT syndrome</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Bradycardia, fatigue, dizziness</li>
              <li>QT prolongation, torsades de pointes</li>
              <li>Bronchospasm</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://www.ncbi.nlm.nih.gov/books/NBK534832/" target="_blank">StatPearls</a><sup><a href="#fn4">[4]</a></sup>
            </div>
          </div>
        </div>

        <!-- Labetalol -->
        <div class="drug-card">
          <div class="drug-header gen3">
            <div class="drug-name">Labetalol</div>
            <div class="drug-brand">Trandate</div>
            <span class="drug-class">3rd Gen Non-Selective + Alpha Blocker</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Combined alpha and beta blocker - the drug of choice for pregnancy-induced hypertension and pre-eclampsia. Available in IV form for hypertensive emergencies. Better birth weights compared to atenolol.<sup><a href="#fn17">[17]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Pregnancy HTN</span>
              <span class="drug-tag">Pre-eclampsia</span>
              <span class="drug-tag">HTN Emergencies</span>
              <span class="drug-tag">Hypertension</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Drug of choice for pregnancy hypertension<sup><a href="#fn17">[17]</a></sup></li>
              <li>Rapid IV form for emergencies</li>
              <li>Better birth weights than atenolol in pregnancy<sup><a href="#fn17">[17]</a></sup></li>
              <li>Does not significantly affect HR or cardiac output</li>
              <li>Lower lipophilicity - less placental/CNS transfer</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>Non-selective - caution in asthma</li>
              <li>Postural hypotension (due to alpha-blockade)</li>
              <li>Requires multiple daily doses orally</li>
              <li>Alpha:beta ratio varies (oral 1:3, IV 1:7)<sup><a href="#fn18">[18]</a></sup></li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Dizziness, fatigue, nausea</li>
              <li>Nasal congestion, scalp tingling</li>
              <li>Postural hypotension</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1429751/" target="_blank">PMC</a><sup><a href="#fn17">[17]</a></sup>,
              <a href="https://www.ncbi.nlm.nih.gov/books/NBK534787/" target="_blank">StatPearls</a><sup><a href="#fn18">[18]</a></sup>
            </div>
          </div>
        </div>

        <!-- Esmolol -->
        <div class="drug-card">
          <div class="drug-header gen2">
            <div class="drug-name">Esmolol</div>
            <div class="drug-brand">Brevibloc</div>
            <span class="drug-class">2nd Generation - Beta-1 Selective (IV Only)</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Ultra-short acting IV beta blocker for emergency and perioperative use. Rapid onset (2 min), very short half-life (9 min), and effects gone 15-30 min after stopping. Ideal when quick reversibility is needed.<sup><a href="#fn19">[19]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">SVT (Acute)</span>
              <span class="drug-tag">Perioperative</span>
              <span class="drug-tag">HTN Emergency</span>
              <span class="drug-tag">ACS</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Ultra-short acting (half-life 9 min)<sup><a href="#fn19">[19]</a></sup></li>
              <li>Rapid onset (2 minutes)</li>
              <li>Easily titratable</li>
              <li>Effects reverse rapidly when stopped</li>
              <li>Metabolism not dependent on liver/kidney</li>
              <li>Ideal for testing beta-blocker tolerance</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>IV only - not for chronic use</li>
              <li>Requires continuous monitoring</li>
              <li>Can cause injection site reactions</li>
              <li>Hypotension with rapid boluses</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Hypotension, bradycardia</li>
              <li>Injection site reactions, nausea</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://www.ncbi.nlm.nih.gov/books/NBK518965/" target="_blank">StatPearls</a><sup><a href="#fn19">[19]</a></sup>
            </div>
          </div>
        </div>

        <!-- Nadolol -->
        <div class="drug-card">
          <div class="drug-header gen1">
            <div class="drug-name">Nadolol</div>
            <div class="drug-brand">Corgard</div>
            <span class="drug-class">1st Generation - Non-Selective</span>
          </div>
          <div class="drug-body">
            <p class="drug-description">
              Long-acting non-selective beta blocker - the PREFERRED agent for Long QT Syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). More effective than propranolol for preventing breakthrough cardiac events.<sup><a href="#fn20">[20]</a></sup>
            </p>

            <div class="drug-section-title">Primary Uses</div>
            <div class="drug-tags">
              <span class="drug-tag">Long QT Syndrome</span>
              <span class="drug-tag">CPVT</span>
              <span class="drug-tag">Hypertension</span>
              <span class="drug-tag">Migraine</span>
            </div>

            <div class="drug-section-title">Benefits</div>
            <ul class="drug-list benefits">
              <li>Very long half-life - once daily dosing</li>
              <li>Preferred agent for LQTS and CPVT<sup><a href="#fn20">[20]</a></sup></li>
              <li>More efficacious than propranolol for cardiac events</li>
              <li>Does not cross blood-brain barrier well (fewer CNS effects)</li>
            </ul>

            <div class="drug-section-title">Drawbacks</div>
            <ul class="drug-list drawbacks">
              <li>Non-selective - avoid in asthma</li>
              <li>Requires dose adjustment in renal impairment</li>
              <li>Can accumulate in kidney disease</li>
            </ul>

            <div class="drug-section-title">Side Effects</div>
            <ul class="drug-list side-effects">
              <li>Fatigue, dizziness, cold extremities</li>
              <li>Bradycardia, bronchospasm</li>
            </ul>

            <div class="drug-source">
              Sources: <a href="https://reference.medscape.com/drug/corgard-nadolol-342361" target="_blank">Medscape</a><sup><a href="#fn20">[20]</a></sup>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- Comparison Table -->
    <section class="data-section" id="comparison">
      <div class="section-header">
        <h2 class="section-title">Beta Blocker Comparison</h2>
      </div>

      <div class="comparison-table-wrapper">
        <table class="comparison-table">
          <thead>
            <tr>
              <th>Drug</th>
              <th>Generation</th>
              <th>Selectivity</th>
              <th>Dosing</th>
              <th>HF Mortality Evidence</th>
              <th>Special Features</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td class="drug-name-cell">Metoprolol</td>
              <td><span class="badge badge-gen2">2nd Gen</span></td>
              <td><span class="badge badge-selective">Beta-1</span></td>
              <td>QD (succinate) or BID (tartrate)</td>
              <td>Yes<sup><a href="#fn8">[8]</a></sup></td>
              <td>Most prescribed; 2 formulations</td>
            </tr>
            <tr>
              <td class="drug-name-cell">Carvedilol</td>
              <td><span class="badge badge-gen3">3rd Gen</span></td>
              <td><span class="badge badge-nonselective">Non-selective + Alpha</span></td>
              <td>BID</td>
              <td>Yes<sup><a href="#fn8">[8]</a></sup></td>
              <td>Metabolically neutral; best for diabetics</td>
            </tr>
            <tr>
              <td class="drug-name-cell">Bisoprolol</td>
              <td><span class="badge badge-gen2">2nd Gen</span></td>
              <td><span class="badge badge-selective">Beta-1 (High)</span></td>
              <td>QD</td>
              <td>Yes<sup><a href="#fn8">[8]</a></sup></td>
              <td>Best in HF + COPD<sup><a href="#fn12">[12]</a></sup></td>
            </tr>
            <tr>
              <td class="drug-name-cell">Propranolol</td>
              <td><span class="badge badge-gen1">1st Gen</span></td>
              <td><span class="badge badge-nonselective">Non-selective</span></td>
              <td>BID-QID</td>
              <td>Yes (post-MI)</td>
              <td>Best for tremor, anxiety, hyperthyroidism</td>
            </tr>
            <tr>
              <td class="drug-name-cell">Atenolol</td>
              <td><span class="badge badge-gen2">2nd Gen</span></td>
              <td><span class="badge badge-selective">Beta-1</span></td>
              <td>QD</td>
              <td>No<sup><a href="#fn15">[15]</a></sup></td>
              <td>Renal adjustment needed; inferior to metoprolol</td>
            </tr>
            <tr>
              <td class="drug-name-cell">Nebivolol</td>
              <td><span class="badge badge-gen3">3rd Gen</span></td>
              <td><span class="badge badge-selective">Beta-1 + NO</span></td>
              <td>QD</td>
              <td>Yes (Europe)</td>
              <td>Only NO-releasing BB; best tolerability<sup><a href="#fn13">[13]</a></sup></td>
            </tr>
            <tr>
              <td class="drug-name-cell">Sotalol</td>
              <td><span class="badge badge-gen1">1st Gen</span></td>
              <td><span class="badge badge-nonselective">Non-selective</span></td>
              <td>BID</td>
              <td>No</td>
              <td>Antiarrhythmic; QT prolongation risk<sup><a href="#fn4">[4]</a></sup></td>
            </tr>
            <tr>
              <td class="drug-name-cell">Labetalol</td>
              <td><span class="badge badge-gen3">3rd Gen</span></td>
              <td><span class="badge badge-nonselective">Non-selective + Alpha</span></td>
              <td>BID-TID</td>
              <td>No</td>
              <td>Pregnancy drug of choice<sup><a href="#fn17">[17]</a></sup></td>
            </tr>
            <tr>
              <td class="drug-name-cell">Esmolol</td>
              <td><span class="badge badge-gen2">2nd Gen</span></td>
              <td><span class="badge badge-selective">Beta-1</span></td>
              <td>IV continuous</td>
              <td>N/A</td>
              <td>Ultra-short acting (t1/2=9 min)<sup><a href="#fn19">[19]</a></sup></td>
            </tr>
            <tr>
              <td class="drug-name-cell">Nadolol</td>
              <td><span class="badge badge-gen1">1st Gen</span></td>
              <td><span class="badge badge-nonselective">Non-selective</span></td>
              <td>QD</td>
              <td>No</td>
              <td>Preferred for LQTS/CPVT<sup><a href="#fn20">[20]</a></sup></td>
            </tr>
          </tbody>
        </table>
      </div>
    </section>

    <!-- Side Effects -->
    <section class="data-section" id="side-effects">
      <div class="section-header">
        <div>
          <h2 class="section-title">Side Effects Overview</h2>
          <p class="section-subtitle">Common and serious side effects of beta blockers</p>
        </div>
      </div>

      <div class="side-effects-grid">
        <div class="side-effect-category">
          <h3 class="side-effect-title common">Very Common</h3>
          <ul class="side-effect-list">
            <li>Fatigue / Tiredness</li>
            <li>Bradycardia (slow heart rate)</li>
            <li>Dizziness / Lightheadedness</li>
            <li>Cold hands and feet</li>
            <li>Hypotension (low blood pressure)</li>
          </ul>
          <div class="stat-source">Source: <a href="https://my.clevelandclinic.org/health/treatments/22318-beta-blockers" target="_blank">Cleveland Clinic</a><sup><a href="#fn21">[21]</a></sup></div>
        </div>

        <div class="side-effect-category">
          <h3 class="side-effect-title common">Common</h3>
          <ul class="side-effect-list">
            <li>Weight gain</li>
            <li>GI upset (nausea, diarrhea, constipation)</li>
            <li>Sleep disturbances</li>
            <li>Vivid dreams / Nightmares</li>
            <li>Headache</li>
          </ul>
          <div class="stat-source">Source: <a href="https://www.escardio.org/Education/ESC-Prevention-of-CVD-Programme/Treatment-goals/Cardio-Protective-drugs/beta-blockers" target="_blank">ESC</a><sup><a href="#fn22">[22]</a></sup></div>
        </div>

        <div class="side-effect-category">
          <h3 class="side-effect-title uncommon">Less Common</h3>
          <ul class="side-effect-list">
            <li>Depression</li>
            <li>Erectile dysfunction</li>
            <li>Bronchospasm</li>
            <li>Muscle cramps</li>
            <li>Blurred vision</li>
            <li>Rash</li>
          </ul>
          <div class="stat-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK532906/" target="_blank">StatPearls</a><sup><a href="#fn6">[6]</a></sup></div>
        </div>

        <div class="side-effect-category">
          <h3 class="side-effect-title serious">Serious (Seek Care)</h3>
          <ul class="side-effect-list">
            <li>Severe bradycardia</li>
            <li>Heart block</li>
            <li>Heart failure exacerbation</li>
            <li>Severe bronchospasm</li>
            <li>QT prolongation (sotalol)</li>
            <li>Torsades de pointes (sotalol)</li>
          </ul>
          <div class="stat-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK532906/" target="_blank">StatPearls</a><sup><a href="#fn6">[6]</a></sup></div>
        </div>
      </div>
    </section>

    <!-- Withdrawal -->
    <section class="data-section" id="withdrawal">
      <div class="section-header">
        <div>
          <h2 class="section-title">Withdrawal Syndrome</h2>
          <p class="section-subtitle">NEVER stop beta blockers abruptly - always taper gradually</p>
        </div>
      </div>

      <div class="data-grid">
        <div class="chart-card">
          <h3 class="chart-title">Withdrawal Timeline</h3>
          <p class="chart-subtitle">What happens when beta blockers are stopped abruptly</p>

          <div class="timeline" style="margin-top: 1.5rem;">
            <div class="timeline-item">
              <div class="timeline-time">0 hours - Last dose</div>
              <div class="timeline-content">Drug levels begin to decline</div>
            </div>
            <div class="timeline-item warning">
              <div class="timeline-time">24-36 hours</div>
              <div class="timeline-content">Symptoms begin: tachycardia, palpitations, sweating<sup><a href="#fn3">[3]</a></sup></div>
            </div>
            <div class="timeline-item danger">
              <div class="timeline-time">48 hours</div>
              <div class="timeline-content">Heart rate reaches maximum increase<sup><a href="#fn3">[3]</a></sup></div>
            </div>
            <div class="timeline-item danger">
              <div class="timeline-time">48-72 hours</div>
              <div class="timeline-content">Peak symptoms: hypertension, chest pain, anxiety, headache<sup><a href="#fn9">[9]</a></sup></div>
            </div>
            <div class="timeline-item warning">
              <div class="timeline-time">7 days</div>
              <div class="timeline-content">Significant improvement in heart rate<sup><a href="#fn3">[3]</a></sup></div>
            </div>
            <div class="timeline-item">
              <div class="timeline-time">1-2 weeks</div>
              <div class="timeline-content">Symptoms generally resolve</div>
            </div>
          </div>
        </div>

        <div class="chart-card">
          <h3 class="chart-title">Withdrawal Symptoms</h3>
          <ul class="drug-list" style="margin-top: 1rem;">
            <li>Tachycardia (rapid heart rate)<sup><a href="#fn9">[9]</a></sup></li>
            <li>Hypertension (elevated blood pressure)</li>
            <li>Palpitations</li>
            <li>Sweating</li>
            <li>Headache</li>
            <li>Tremor</li>
            <li>Anxiety / Agitation</li>
            <li>Chest pain (angina)</li>
            <li>Nervousness</li>
            <li>Nausea</li>
          </ul>

          <h3 class="chart-title" style="margin-top: 1.5rem;">Serious Risks</h3>
          <ul class="drug-list drawbacks">
            <li>Unstable angina<sup><a href="#fn9">[9]</a></sup></li>
            <li>Myocardial infarction (heart attack)</li>
            <li>Sudden death (in CAD patients)</li>
            <li>Increased postoperative complications</li>
          </ul>
        </div>

        <div class="chart-card">
          <h3 class="chart-title">Withdrawal by Drug</h3>
          <p class="chart-subtitle">Frequency of withdrawal symptoms in clinical studies</p>
          <div class="chart-container" style="height: 250px;">
            <canvas id="withdrawalChart"></canvas>
          </div>
          <div class="stat-source" style="margin-top: 0.5rem;">Source: <a href="https://www.sciencedirect.com/science/article/abs/pii/0002870382901429" target="_blank">ScienceDirect</a><sup><a href="#fn11">[11]</a></sup></div>
        </div>

        <div class="chart-card">
          <h3 class="chart-title">Safe Discontinuation</h3>
          <ul class="drug-list benefits" style="margin-top: 1rem;">
            <li><strong>NEVER</strong> stop beta blockers abruptly<sup><a href="#fn23">[23]</a></sup></li>
            <li>Taper gradually over 1-2 weeks minimum</li>
            <li>Reduce dose by 25-50% every few days</li>
            <li>Monitor closely during taper</li>
            <li>Agents with ISA (pindolol, acebutolol) have milder withdrawal<sup><a href="#fn11">[11]</a></sup></li>
            <li>Contact doctor immediately if chest pain or severe symptoms</li>
          </ul>
        </div>
      </div>
    </section>

    <!-- Recommendations -->
    <section class="data-section" id="recommendations">
      <div class="section-header">
        <div>
          <h2 class="section-title">When to Use Which Beta Blocker</h2>
          <p class="section-subtitle">Condition-based recommendations from clinical guidelines</p>
        </div>
      </div>

      <div class="indication-grid">
        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#10084;</span> Heart Failure (HFrEF)</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Carvedilol</span>
            <span class="indication-drug primary">Bisoprolol</span>
            <span class="indication-drug primary">Metoprolol Succinate</span>
            <span class="indication-drug">Nebivolol</span>
          </div>
          <div class="indication-note">Only these have mortality evidence in heart failure. Start low, go slow.</div>
          <div class="indication-source">Source: <a href="https://www.escardio.org/Education/ESC-Prevention-of-CVD-Programme/Treatment-goals/Cardio-Protective-drugs/beta-blockers" target="_blank">ESC</a><sup><a href="#fn22">[22]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#129657;</span> Post-MI</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Metoprolol</span>
            <span class="indication-drug primary">Carvedilol</span>
            <span class="indication-drug">Propranolol</span>
            <span class="indication-drug">Timolol</span>
          </div>
          <div class="indication-note">Atenolol has NOT shown mortality benefit post-MI. May discontinue after 1 year if EF 50%.</div>
          <div class="indication-source">Source: <a href="https://www.jacc.org/doi/10.1016/j.jacadv.2024.101582" target="_blank">JACC</a><sup><a href="#fn15">[15]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128568;</span> Asthma / COPD</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Bisoprolol</span>
            <span class="indication-drug">Metoprolol</span>
            <span class="indication-drug">Nebivolol</span>
          </div>
          <div class="indication-note">Cardioselective agents ONLY. Bisoprolol best in HF + COPD. NEVER use non-selective agents.</div>
          <div class="indication-source">Source: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7917232/" target="_blank">PMC</a><sup><a href="#fn24">[24]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#129360;</span> Diabetes</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Carvedilol</span>
            <span class="indication-drug primary">Nebivolol</span>
          </div>
          <div class="indication-note">Metabolically neutral - don't worsen insulin resistance. Monitor for masked hypoglycemia.</div>
          <div class="indication-source">Source: <a href="https://www.ahajournals.org/doi/10.1161/JAHA.121.021310" target="_blank">JAHA</a><sup><a href="#fn10">[10]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#129328;</span> Pregnancy Hypertension</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Labetalol</span>
          </div>
          <div class="indication-note">Drug of choice. Better birth weights than atenolol. Avoid atenolol in pregnancy.</div>
          <div class="indication-source">Source: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1429751/" target="_blank">PMC</a><sup><a href="#fn17">[17]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128403;</span> Atrial Fibrillation</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Metoprolol</span>
            <span class="indication-drug primary">Bisoprolol</span>
            <span class="indication-drug">Carvedilol</span>
            <span class="indication-drug">Esmolol (acute)</span>
          </div>
          <div class="indication-note">First-line for rate control. Sotalol for rhythm control if needed.</div>
          <div class="indication-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK532906/" target="_blank">StatPearls</a><sup><a href="#fn6">[6]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128556;</span> Performance Anxiety / Tremor</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Propranolol</span>
          </div>
          <div class="indication-note">Crosses blood-brain barrier. Effective for physical symptoms. Used by musicians/speakers.</div>
          <div class="indication-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK557801/" target="_blank">StatPearls</a><sup><a href="#fn5">[5]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#9889;</span> Long QT Syndrome / CPVT</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Nadolol</span>
          </div>
          <div class="indication-note">Preferred agent. More effective than propranolol for preventing breakthrough cardiac events.</div>
          <div class="indication-source">Source: <a href="https://reference.medscape.com/drug/corgard-nadolol-342361" target="_blank">Medscape</a><sup><a href="#fn20">[20]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128293;</span> Hyperthyroidism</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Propranolol</span>
          </div>
          <div class="indication-note">Most studied for thyrotoxicosis. Controls tachycardia and tremor. Inhibits T4T3 at high doses.</div>
          <div class="indication-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK557801/" target="_blank">StatPearls</a><sup><a href="#fn5">[5]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128657;</span> Emergency / IV Use</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Esmolol</span>
            <span class="indication-drug">Labetalol IV</span>
          </div>
          <div class="indication-note">Esmolol: ultra-short acting (t=9 min), titratable, quickly reversible.</div>
          <div class="indication-source">Source: <a href="https://www.ncbi.nlm.nih.gov/books/NBK518965/" target="_blank">StatPearls</a><sup><a href="#fn19">[19]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128065;</span> Glaucoma</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Timolol (topical)</span>
          </div>
          <div class="indication-note">Decreases aqueous humor production. Even eye drops can cause systemic effects.</div>
          <div class="indication-source">Source: <a href="https://www.rxlist.com/beta_blockers/drug-class.htm" target="_blank">RxList</a><sup><a href="#fn25">[25]</a></sup></div>
        </div>

        <div class="indication-card">
          <div class="indication-title"><span class="icon">&#128137;</span> Perioperative</div>
          <div class="indication-drugs">
            <span class="indication-drug primary">Bisoprolol</span>
            <span class="indication-drug primary">Metoprolol Succinate</span>
          </div>
          <div class="indication-note">Start 1 week-30 days pre-surgery. Target HR 60-70, SBP >100. NEVER stop abruptly.</div>
          <div class="indication-source">Source: <a href="https://www.vumc.org/trauma-and-scc/sites/vumc.org.trauma-and-scc/files/public_files/Manual/betaBlockadeGuidelines.pdf" target="_blank">VUMC</a><sup><a href="#fn26">[26]</a></sup></div>
        </div>
      </div>
    </section>

    <!-- Contraindications -->
    <section class="data-section" id="contraindications">
      <div class="section-header">
        <h2 class="section-title">Contraindications</h2>
      </div>

      <div class="contra-grid">
        <div class="contra-card">
          <div class="contra-header absolute">Absolute Contraindications</div>
          <div class="contra-body">
            <ul class="contra-list">
              <li>
                <div class="contra-condition">Symptomatic Bradycardia (&lt;60 bpm)</div>
                <div class="contra-reason">Beta blockers further slow heart rate<sup><a href="#fn27">[27]</a></sup></div>
              </li>
              <li>
                <div class="contra-condition">High-Grade AV Block (without pacemaker)</div>
                <div class="contra-reason">Worsens cardiac conduction</div>
              </li>
              <li>
                <div class="contra-condition">Sick Sinus Syndrome (without pacemaker)</div>
                <div class="contra-reason">Worsens conduction abnormalities</div>
              </li>
              <li>
                <div class="contra-condition">Severe/Uncontrolled Asthma</div>
                <div class="contra-reason">Bronchospasm risk (especially non-selective agents)<sup><a href="#fn24">[24]</a></sup></div>
              </li>
              <li>
                <div class="contra-condition">Decompensated Heart Failure</div>
                <div class="contra-reason">Reduces cardiac output when patient unstable</div>
              </li>
              <li>
                <div class="contra-condition">Cardiogenic Shock</div>
                <div class="contra-reason">Worsens hemodynamics</div>
              </li>
            </ul>
          </div>
        </div>

        <div class="contra-card">
          <div class="contra-header relative">Relative Contraindications</div>
          <div class="contra-body">
            <ul class="contra-list">
              <li>
                <div class="contra-condition">Mild/Controlled Asthma</div>
                <div class="contra-reason">Cardioselective agents may be used cautiously</div>
              </li>
              <li>
                <div class="contra-condition">COPD</div>
                <div class="contra-reason">Cardioselective agents often tolerated</div>
              </li>
              <li>
                <div class="contra-condition">Diabetes</div>
                <div class="contra-reason">Not contraindicated but monitor - can mask hypoglycemia<sup><a href="#fn27">[27]</a></sup></div>
              </li>
              <li>
                <div class="contra-condition">Peripheral Vascular Disease</div>
                <div class="contra-reason">May worsen claudication</div>
              </li>
              <li>
                <div class="contra-condition">Raynaud's Phenomenon</div>
                <div class="contra-reason">Cold extremities worsen symptoms</div>
              </li>
              <li>
                <div class="contra-condition">Depression</div>
                <div class="contra-reason">May exacerbate (lipophilic agents)</div>
              </li>
            </ul>
          </div>
        </div>
      </div>

      <div class="stat-source" style="margin-top: 1rem;">Source: <a href="https://bpac.org.nz/2024/beta-blockers.aspx" target="_blank">BPAC NZ</a><sup><a href="#fn27">[27]</a></sup></div>
    </section>

    <!-- Drug Interactions -->
    <section class="data-section" id="interactions">
      <div class="section-header">
        <div>
          <h2 class="section-title">Drug Interactions</h2>
          <p class="section-subtitle">Important interactions to be aware of</p>
        </div>
      </div>

      <div class="comparison-table-wrapper">
        <table class="interactions-table">
          <thead>
            <tr>
              <th>Interacting Drug</th>
              <th>Severity</th>
              <th>Risk / Effect</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Verapamil / Diltiazem</td>
              <td><span class="severity-high">HIGH</span></td>
              <td>Severe bradycardia, heart block, hypotension<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>Clonidine</td>
              <td><span class="severity-high">HIGH</span></td>
              <td>Rebound hypertension on withdrawal<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>Digoxin</td>
              <td><span class="severity-high">HIGH</span></td>
              <td>Bradycardia, toxicity (especially with sotalol)<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>Class I/III Antiarrhythmics</td>
              <td><span class="severity-high">HIGH</span></td>
              <td>Additive effects, QT prolongation</td>
            </tr>
            <tr>
              <td>Thioridazine / Chlorpromazine</td>
              <td><span class="severity-high">HIGH</span></td>
              <td>Increased drug levels, arrhythmia risk<sup><a href="#fn29">[29]</a></sup></td>
            </tr>
            <tr>
              <td>NSAIDs</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Reduced antihypertensive effect<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>SSRIs (fluoxetine, paroxetine)</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Increased beta blocker levels<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>Amiodarone</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Bradycardia, increased metoprolol levels</td>
            </tr>
            <tr>
              <td>Alcohol</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Additive hypotension, dizziness, fainting<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>Pseudoephedrine</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Antagonizes blood pressure lowering<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
            <tr>
              <td>Stimulants (caffeine, amphetamines)</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Antagonizes beta blocker effects</td>
            </tr>
            <tr>
              <td>Hawthorn</td>
              <td><span class="severity-moderate">MODERATE</span></td>
              <td>Potentiates effect - excessive BP lowering<sup><a href="#fn28">[28]</a></sup></td>
            </tr>
          </tbody>
        </table>
      </div>

      <div class="stat-source" style="margin-top: 1rem;">Source: <a href="https://www.goodrx.com/classes/beta-blockers/interactions" target="_blank">GoodRx</a><sup><a href="#fn28">[28]</a></sup></div>
    </section>

    <!-- Sources / Footnotes -->
    <section class="data-section" id="sources">
      <div class="footnotes">
        <h2 class="footnotes-title">Sources & References</h2>

        <div class="footnote-item" id="fn1">
          <span class="footnote-number">[1]</span>
          <span class="footnote-text"><a href="https://www.definitivehc.com/blog/beta-blocker-prescription-patterns" target="_blank">Definitive Healthcare - Most common beta blockers in 2024</a></span>
        </div>
        <div class="footnote-item" id="fn2">
          <span class="footnote-number">[2]</span>
          <span class="footnote-text"><a href="https://pubmed.ncbi.nlm.nih.gov/30227820/" target="_blank">PubMed - Three Generations of -blockers: History, Class Differences and Clinical Applicability</a></span>
        </div>
        <div class="footnote-item" id="fn3">
          <span class="footnote-number">[3]</span>
          <span class="footnote-text"><a href="https://pubmed.ncbi.nlm.nih.gov/37093/" target="_blank">European Journal of Clinical Pharmacology - Abrupt withdrawal of beta-blocking agents</a></span>
        </div>
        <div class="footnote-item" id="fn4">
          <span class="footnote-number">[4]</span>
          <span class="footnote-text"><a href="https://www.ncbi.nlm.nih.gov/books/NBK534832/" target="_blank">StatPearls - Sotalol</a></span>
        </div>
        <div class="footnote-item" id="fn5">
          <span class="footnote-number">[5]</span>
          <span class="footnote-text"><a href="https://www.ncbi.nlm.nih.gov/books/NBK557801/" target="_blank">StatPearls - Propranolol</a></span>
        </div>
        <div class="footnote-item" id="fn6">
          <span class="footnote-number">[6]</span>
          <span class="footnote-text"><a href="https://www.ncbi.nlm.nih.gov/books/NBK532906/" target="_blank">StatPearls - Beta Blockers</a></span>
        </div>
        <div class="footnote-item" id="fn7">
          <span class="footnote-number">[7]</span>
          <span class="footnote-text"><a href="https://onlinelibrary.wiley.com/doi/10.1111/bcpt.12396" target="_blank">Wiley - Third-Generation Beta-Adrenoceptor Antagonists</a></span>
        </div>
        <div class="footnote-item" id="fn8">
          <span class="footnote-number">[8]</span>
          <span class="footnote-text"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9823244/" target="_blank">PMC - Effectiveness and safety of four different beta-blockers in CHF</a></span>
        </div>
        <div class="footnote-item" id="fn9">
          <span class="footnote-number">[9]</span>
          <span class="footnote-text"><a href="https://pubmed.ncbi.nlm.nih.gov/2883874/" target="_blank">PubMed - Beta-adrenergic blocker withdrawal</a></span>
        </div>
        <div class="footnote-item" id="fn10">
          <span class="footnote-number">[10]</span>
          <span class="footnote-text"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.121.021310" target="_blank">JAHA - Carvedilol vs Metoprolol in Heart Failure with Type 2 Diabetes</a></span>
        </div>
        <div class="footnote-item" id="fn11">
          <span class="footnote-number">[11]</span>
          <span class="footnote-text"><a href="https://www.sciencedirect.com/science/article/abs/pii/0002870382901429" target="_blank">ScienceDirect - Comparison of withdrawal phenomena</a></span>
        </div>
        <div class="footnote-item" id="fn12">
          <span class="footnote-number">[12]</span>
          <span class="footnote-text"><a href="https://link.springer.com/article/10.1007/s00392-017-1115-0" target="_blank">Clinical Research in Cardiology - Bisoprolol compared with carvedilol and metoprolol</a></span>
        </div>
        <div class="footnote-item" id="fn13">
          <span class="footnote-number">[13]</span>
          <span class="footnote-text"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1993984/" target="_blank">PMC - Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation</a></span>
        </div>
        <div class="footnote-item" id="fn14">
          <span class="footnote-number">[14]</span>
          <span class="footnote-text"><a href="https://www.singlecare.com/blog/metoprolol-vs-atenolol/" target="_blank">SingleCare - Metoprolol vs. atenolol comparison</a></span>
        </div>
        <div class="footnote-item" id="fn15">
          <span class="footnote-number">[15]</span>
          <span class="footnote-text"><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2024.101582" target="_blank">JACC Advances - Beta-Blocker Therapy After Myocardial Infarction</a></span>
        </div>
        <div class="footnote-item" id="fn16">
          <span class="footnote-number">[16]</span>
          <span class="footnote-text"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3183837/" target="_blank">PMC - When not to use beta-blockers in seniors with hypertension</a></span>
        </div>
        <div class="footnote-item" id="fn17">
          <span class="footnote-number">[17]</span>
          <span class="footnote-text"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1429751/" target="_blank">PMC - Use of labetalol in treatment of severe hypertension during pregnancy</a></span>
        </div>
        <div class="footnote-item" id="fn18">
          <span class="footnote-number">[18]</span>
          <span class="footnote-text"><a href="https://www.ncbi.nlm.nih.gov/books/NBK534787/" target="_blank">StatPearls - Labetalol</a></span>
        </div>
        <div class="footnote-item" id="fn19">
          <span class="footnote-number">[19]</span>
          <span class="footnote-text"><a href="https://www.ncbi.nlm.nih.gov/books/NBK518965/" target="_blank">StatPearls - Esmolol</a></span>
        </div>
        <div class="footnote-item" id="fn20">
          <span class="footnote-number">[20]</span>
          <span class="footnote-text"><a href="https://reference.medscape.com/drug/corgard-nadolol-342361" target="_blank">Medscape - Nadolol dosing, indications, interactions</a></span>
        </div>
        <div class="footnote-item" id="fn21">
          <span class="footnote-number">[21]</span>
          <span class="footnote-text"><a href="https://my.clevelandclinic.org/health/treatments/22318-beta-blockers" target="_blank">Cleveland Clinic - Beta-Blockers: Uses & Side Effects</a></span>
        </div>
        <div class="footnote-item" id="fn22">
          <span class="footnote-number">[22]</span>
          <span class="footnote-text"><a href="https://www.escardio.org/Education/ESC-Prevention-of-CVD-Programme/Treatment-goals/Cardio-Protective-drugs/beta-blockers" target="_blank">European Society of Cardiology - Beta-blockers</a></span>
        </div>
        <div class="footnote-item" id="fn23">
          <span class="footnote-number">[23]</span>
          <span class="footnote-text"><a href="https://www.talkspace.com/blog/propranolol-withdrawal/" target="_blank">Talkspace - Propranolol Withdrawal</a></span>
        </div>
        <div class="footnote-item" id="fn24">
          <span class="footnote-number">[24]</span>
          <span class="footnote-text"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7917232/" target="_blank">PMC - Safety of cardioselective 1-blockers in asthma</a></span>
        </div>
        <div class="footnote-item" id="fn25">
          <span class="footnote-number">[25]</span>
          <span class="footnote-text"><a href="https://www.rxlist.com/beta_blockers/drug-class.htm" target="_blank">RxList - Beta Blockers: List, Side Effects</a></span>
        </div>
        <div class="footnote-item" id="fn26">
          <span class="footnote-number">[26]</span>
          <span class="footnote-text"><a href="https://www.vumc.org/trauma-and-scc/sites/vumc.org.trauma-and-scc/files/public_files/Manual/betaBlockadeGuidelines.pdf" target="_blank">VUMC - Perioperative Beta Blockade Guidelines</a></span>
        </div>
        <div class="footnote-item" id="fn27">
          <span class="footnote-number">[27]</span>
          <span class="footnote-text"><a href="https://bpac.org.nz/2024/beta-blockers.aspx" target="_blank">BPAC NZ - Beta blockers for cardiovascular conditions</a></span>
        </div>
        <div class="footnote-item" id="fn28">
          <span class="footnote-number">[28]</span>
          <span class="footnote-text"><a href="https://www.goodrx.com/classes/beta-blockers/interactions" target="_blank">GoodRx - 7 Beta Blocker Interactions to Be Aware Of</a></span>
        </div>
        <div class="footnote-item" id="fn29">
          <span class="footnote-number">[29]</span>
          <span class="footnote-text"><a href="https://www.medicinenet.com/beta_blockers/article.htm" target="_blank">MedicineNet - Beta Blockers: Side Effects, Interactions</a></span>
        </div>
      </div>
    </section>
  </main>

  <footer class="dashboard-footer">
    <div class="footer-content">
      <div class="footer-disclaimer">
        <strong>Medical Disclaimer:</strong> This dashboard is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Never stop taking beta blockers abruptly without medical supervision.
      </div>
      <p style="font-size: 0.875rem; color: var(--color-text-light);">
        Data compiled from peer-reviewed medical literature and authoritative clinical sources. Last updated: December 18, 2025.
      </p>
    </div>
  </footer>

  <button class="theme-toggle" onclick="toggleTheme()">
    <span id="themeIcon">&#9790;</span> Toggle Dark Mode
  </button>

  <button class="scroll-top" onclick="scrollToTop()" id="scrollTop">&#8593;</button>

  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  <script>
    // Theme toggle
    function toggleTheme() {
      const html = document.documentElement;
      const themeIcon = document.getElementById('themeIcon');
      html.toggleAttribute('data-theme');
      localStorage.setItem('theme', html.hasAttribute('data-theme') ? 'dark' : 'light');
      themeIcon.innerHTML = html.hasAttribute('data-theme') ? '&#9788;' : '&#9790;';
      updateChartColors();
    }

    if (localStorage.getItem('theme') === 'dark') {
      document.documentElement.setAttribute('data-theme', 'dark');
      document.getElementById('themeIcon').innerHTML = '&#9788;';
    }

    // Navigation scroll spy
    const sections = document.querySelectorAll('.data-section');
    const navItems = document.querySelectorAll('.nav-item');

    window.addEventListener('scroll', () => {
      let current = 'overview';
      sections.forEach(section => {
        const sectionTop = section.offsetTop;
        if (scrollY >= sectionTop - 200) {
          current = section.getAttribute('id') || 'overview';
        }
      });

      navItems.forEach(item => {
        item.classList.remove('active');
        if (item.getAttribute('href') === '#' + current) {
          item.classList.add('active');
        }
      });

      // Scroll to top button
      const scrollTop = document.getElementById('scrollTop');
      if (window.scrollY > 500) {
        scrollTop.classList.add('show');
      } else {
        scrollTop.classList.remove('show');
      }
    });

    // Smooth scroll for nav
    navItems.forEach(item => {
      item.addEventListener('click', (e) => {
        e.preventDefault();
        const target = document.querySelector(item.getAttribute('href'));
        if (target) {
          target.scrollIntoView({ behavior: 'smooth' });
        }
      });
    });

    function scrollToTop() {
      window.scrollTo({ top: 0, behavior: 'smooth' });
    }

    // Chart colors based on theme
    function getChartColors() {
      const isDark = document.documentElement.hasAttribute('data-theme');
      return {
        text: isDark ? '#F9FAFB' : '#1F2937',
        grid: isDark ? '#374151' : '#E5E7EB',
        primary: '#3B82F6',
        success: '#10B981',
        warning: '#F59E0B',
        danger: '#EF4444',
        purple: '#8B5CF6',
        pink: '#EC4899'
      };
    }

    let marketShareChart, withdrawalChart;

    function createCharts() {
      const colors = getChartColors();

      // Market Share Chart
      const marketShareCtx = document.getElementById('marketShareChart').getContext('2d');
      marketShareChart = new Chart(marketShareCtx, {
        type: 'bar',
        data: {
          labels: ['Metoprolol\nSuccinate', 'Carvedilol', 'Metoprolol\nTartrate', 'Propranolol', 'Atenolol', 'Other'],
          datasets: [{
            label: 'Market Share (%)',
            data: [36.9, 17.2, 16.7, 8.4, 7.3, 13.5],
            backgroundColor: [
              colors.primary,
              colors.success,
              '#60A5FA',
              colors.purple,
              colors.warning,
              '#9CA3AF'
            ],
            borderRadius: 6,
            borderSkipped: false,
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            legend: {
              display: false
            },
            tooltip: {
              callbacks: {
                label: function(context) {
                  return context.parsed.y + '% of prescriptions';
                }
              }
            }
          },
          scales: {
            y: {
              beginAtZero: true,
              max: 45,
              grid: {
                color: colors.grid
              },
              ticks: {
                color: colors.text,
                callback: function(value) {
                  return value + '%';
                }
              }
            },
            x: {
              grid: {
                display: false
              },
              ticks: {
                color: colors.text,
                font: {
                  size: 11
                }
              }
            }
          }
        }
      });

      // Withdrawal Chart
      const withdrawalCtx = document.getElementById('withdrawalChart').getContext('2d');
      withdrawalChart = new Chart(withdrawalCtx, {
        type: 'bar',
        data: {
          labels: ['Propranolol', 'Metoprolol', 'Pindolol'],
          datasets: [{
            label: 'Patients with Withdrawal Symptoms (%)',
            data: [67, 38, 14],
            backgroundColor: [
              colors.danger,
              colors.warning,
              colors.success
            ],
            borderRadius: 6,
            borderSkipped: false,
          }]
        },
        options: {
          indexAxis: 'y',
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            legend: {
              display: false
            },
            tooltip: {
              callbacks: {
                label: function(context) {
                  return context.parsed.x + '% experienced withdrawal symptoms';
                }
              }
            }
          },
          scales: {
            x: {
              beginAtZero: true,
              max: 100,
              grid: {
                color: colors.grid
              },
              ticks: {
                color: colors.text,
                callback: function(value) {
                  return value + '%';
                }
              }
            },
            y: {
              grid: {
                display: false
              },
              ticks: {
                color: colors.text
              }
            }
          }
        }
      });
    }

    function updateChartColors() {
      const colors = getChartColors();

      if (marketShareChart) {
        marketShareChart.options.scales.y.grid.color = colors.grid;
        marketShareChart.options.scales.y.ticks.color = colors.text;
        marketShareChart.options.scales.x.ticks.color = colors.text;
        marketShareChart.update();
      }

      if (withdrawalChart) {
        withdrawalChart.options.scales.x.grid.color = colors.grid;
        withdrawalChart.options.scales.x.ticks.color = colors.text;
        withdrawalChart.options.scales.y.ticks.color = colors.text;
        withdrawalChart.update();
      }
    }

    // Initialize charts
    createCharts();
  </script>
</body>
</html>
